TransMedics Group, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
TMDX$93.79+6.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share amounts)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash | $488,366 | $336,650 |
| Accounts receivable | 84,282 | 97,722 |
| Inventory | 48,881 | 46,554 |
| Prepaid expenses and other current assets | 16,254 | 16,290 |
| Total current assets | 637,783 | 497,216 |
| Property, plant and equipment, net | 327,656 | 285,970 |
| Operating lease right-of-use assets | 5,155 | 6,481 |
| Deferred tax assets | 83,543 | — |
| Restricted cash | 500 | 500 |
| Goodwill | 11,549 | 11,549 |
| Acquired intangible assets, net | 1,948 | 2,152 |
| Other non-current assets | 239 | 208 |
| Total assets | $1,068,373 | $804,076 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $10,350 | $10,292 |
| Accrued expenses and other current liabilities | 62,740 | 45,152 |
| Current portion of long-term debt | 10,000 | — |
| Deferred revenue | 2,905 | 1,742 |
| Operating lease liabilities | 3,310 | 2,727 |
| Total current liabilities | 89,305 | 59,913 |
| Convertible senior notes, net | 452,804 | 449,939 |
| Long-term debt, net | 49,587 | 59,372 |
| Operating lease liabilities, net of current portion | 3,577 | 6,249 |
| Total liabilities | 595,273 | 575,473 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity: | ||
| Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding | — | — |
| Common stock, no par value; 150,000,000 shares authorized; 34,267,802 shares and 33,617,972 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 750,926 | 697,208 |
| Accumulated other comprehensive income (loss) | 124 | (364) |
| Accumulated deficit | (277,950) | (468,241) |
| Total stockholders' equity | 473,100 | 228,603 |
| Total liabilities and stockholders' equity | $1,068,373 | $804,076 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.